[1] Paul Vanhoutte, Michel Feletou, Stefano Taddei. Endothelium-dependent contractions in hypertension[J]. Br J Pharmacol, 2005, 144(4): 449-458.
[2] Guan Zheng-rong, Justin P Van Beusecum, Edward W Inscho. Endothelin and the renal microcirculation[J]. Semin Nephrol, 2015, 35(2): 145-155.
[3] Rina Meidan, Nitzan Levy. The ovarian endothelin network: an evolving story[J].Trends Endocrinol Metab, 2007, 18(10): 379-385.
[4] Martin Smollich, Pai Wulfing. The endothelin axis: a novel target for pharmacotherapy of female malignancies[J]. Curr Vasc Pharmacol, 2007, 5(3): 239-248.
[5] 张蕾, 阮君山, 严令耕, 等. 内皮素和一氧化氮致血管损伤性疾病的分子机制及药物研发策略[J]. 中国药理学通报, 2012, 28(2): 162-165.
[6] Matthew Jankowich, Gaurav Choudhary. Endothelin-1 levels and cardiovascular events[J]. Trends Cardiovasc Med, 2019, (1):7.
[7] Anthony Davenport, Kelly Hyndman, Neeraj Dhaun, et al. Endothelin[J]. Pharmacol Rev, 2016, 68(2): 357-418.
[8] Saleh Langeza, Danser Jan A H, van den Meiracher Anton H. Role of endothelin in preeclampsia and hypertension following antiangiogenesis treatment[J]. Curr Opin Nephrol Hypertens, 2016, 25(2): 94-99.
[9] Takashi Miyauchi, Satoshi Sakai. Endothelin and the heart in health and diseases[J]. Peptides, 2018, 111: 77-88.
[10] Motte S, Mcentee K, Naeije R. Endothelin receptor antagonists[J]. Pharmacol Ther, 2006, 110(3): 386-414.
[11] Dupuis J, Hoeper M. Endothelin receptor antagonists in pulmonary arterial hypertension[J]. Eur Respir J, 2008, 31(2): 407-415.
[12] Feletou M, Vanhoutte P M. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)[J]. Am J Physiol Heart Circ Physiol, 2006, 291(3): 985-1002.
[13] William Rosenblum. Endothelium-dependent responses in the microcirculation observed in vivo[J]. Acta Physiol (Oxf), 2018, 224(2): e13111.
[14] Giuseppe Faraco, Ana Moraga, Jamie Moore, et al. Circulating endothelin-1 alters critical mechanisms regulating cerebral microcirculation[J]. Hypertension, 2013, 62(4): 759-766.
[15] Julia Dolinina, Anna Rippe, Carl M Öberg. Sustained, delayed and small increments in glomerular permeability to macromolecules during systemic endothelin-1 infusion mediated via the ETA receptor[J]. Am J Physiol Renal Physiol, 2019, 316(6):F1173-F1179.
[16] Tal Imbar, Eyal Klipper, Caryn Greenfield, et al. Altered endothelin expression in granulosa-lutein cells of women with polycystic ovary syndrome[J]. Life Sci, 2012, 91(13-14): 703-709.
[17] Sarah Brogger Kristiansen, Kristian Agmund Haanes, Majid Sheykhzade, et al. Endothelin receptor mediated Ca(2+) signaling in coronary arteries after experimentally induced ischemia /reperfusion injury in rat[J]. J Mol Cell Cardiol, 2017, 111:1-9.
[18] Uchide T, Javier Adur, Yoshioka Y, et al. Endothelin-1 in smooth muscle cells and mast cells of mouse uterus after parturition[J]. J Mol Endocrinol, 2001, 27(2): 165-173.
[19] Koumei Shirasuna, Hitomi Asaoka, Tomas J Acosta, et al. Real-time relationships in intraluteal release among prostaglandin F2alpha, endothelin-1, and angiotensin II during spontaneous luteolysis in the cow[J]. Biol Reprod, 2004, 71(5): 1706-1711.
[20] Larry G Thaete, Tamas Jilling, Sylvia Synowiec, et al. Expression of endothelin 1 and its receptors in the hypoxic pregnant rat[J]. Biol Reprod, 2007, 77(3): 526-532.
[21] Mark G Neerhof, Tamas Jilling, Sylvia Synowiec, et al. Altered endothelin receptor binding in response to nitric oxide synthase inhibition in the pregnant rat[J]. Reprod Sci, 2008, 15(4): 366-373.
[22] Ma Kun, Chen Yan-xia, Wang Yan-ying. Impact of prostaglandin F2α and endothelin, pulsation index and resistance index of uterine artery blood flow on dysmenorrhea patients of cold stagnation and blood stasis syndrome with Dingkun Dan[J]. Zhongguo Zhong Yao Za Zhi, 2017, 42(23): 4474-4480.
[23] Shirasuna K, Watanabe S, Yamamoto D, et al. Bovine endothelial cells interact with fully-luteinized, but not luteinizing, granulosa cells in the mRNA expression of endothelin-1 system in response to prostaglandin F(2alpha)[J]. Reprod Domest Anim, 2007, 42(6): 637-642.
[24] Zorrilla L M, Sriperumbudur R, Gadsby J E. Endothelin-1, endothelin converting enzyme-1 and endothelin receptors in the porcine corpus luteum[J]. Domest Anim Endocrinol, 2010, 38(2): 75-85.
[25] Bajram Berisha, Dieter Schams, Akio Miyamoto. The expression of angiotensin and endothelin system members in bovine corpus luteum during estrous cycle and pregnancy[J]. Endocrine, 2002,19(3): 305-312.
[27] 朱虹, 龙子江, 李国忠. 合成水苏碱对功血模型大鼠子宫血管舒缩因子的影响[J]. 江西中医药大学学报, 2008, 20(6):66-68.
[28] 陈志刚, 王红静, 周羽, 等. 内皮素-1及其受体在子宫内膜异位症中的表达及意义[J]. 四川大学学报: 医学版, 2009, 40(3): 422-425.
[29] 王丽, 吕淑兰, 曹缵孙. 青春期与育龄期多囊卵巢综合征患者的临床对照研究[J]. 西安交通大学学报: 医学版, 2010, 31 (6): 745-747.
[30] 陈思宇, 李艳霞, 唐素珍. 艾灸对寒凝血瘀证模型大鼠内皮素及一氧化氮的影响[J]. 实用中医药杂志, 2011, 27(5): 292-293.
[31] Jose A Santiago, Lorena M Amaral, Jessica Faulkner, et al. Serelaxin improves the pathophysiology of placental ischemia in the reduced uterine perfusion pressure (RUPP) rat model of preeclampsia[J]. Am J Physiol Regul Integr Comp Physiol, 2016, 311(6):R1158-R1163.
[32] Aykut Gram, Alois Boos, Mariusz P Kowalewski. Cellular localization expression and functional implications of the utero-placental endothelin system during maintenance and termination of canine gestation[J]. J Reprod Dev, 2017, 63(3): 235-245.
[33] Sara Buttrup Larsen, Gerd Wallukat, Ingolf Schimke, et al. Functional autoantibodies against Endothelin-1 receptor type A and Angiotensin II receptor type 1 in patients with preeclampsia[J]. Pregnancy Hypertens, 2018, 14: 189-194.
[34] Zhou Jian-jun, Xiao Da-liao, Hu Ya-li, et al. Gestational hypoxia induces preeclampsia-like symptoms via heightened endothelin-1 signaling in pregnant rats[J]. Hypertension, 2013, 62(3): 599-607.
[35] Laura Rosano, Anna Bagnato. Endothelin therapeutics in cancer: where are we?[J]. Am J Physiol Regul Integr Comp Physiol, 2016, 310(6): 469-475.
[36] Martin Smollich, Pia Wulfing. The endothelin axis: a novel target for pharmacotherapy of female malignancies[J]. Curr Vasc Pharmacol, 2007, 5(3): 239-248.
[37] 张阿丽, 张弓, 彭晋, 等. 内皮素-1活化ROCK/SLUG诱导人卵巢癌细胞发生上皮向间充质转分化[J].中国药理学通报, 2012, 28 (5): 680-686.
|